HomeMarketsSharesSiemens Healthineers AG

Trade Siemens Healthineers AG - SHL CFD

Market is not available at the momentMarket information is presented
as of 2026-09-25T15:28:11+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.09
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.018013 %
(-€3.60)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.01801%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.004209 %
(-€0.84)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.00421%
Overnight funding adjustment time21:00 (UTC)
CurrencyEUR
Min traded quantity0.1
Margin5.00%
Stock exchangeGermany
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close37.09
Open37.4
1-Year Change-19.52%
Day's Range37.4 - 37.92

Trade Siemens Healthineers AG - SHL

About Siemens Healthineers AG

Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company develops its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare. The Company is active worldwide.

Financial summary

BRIEF: For the three months ended 31 December 2021, Siemens Healthineers AG revenues increased 31% to EUR5.07B. Net income applicable to common stockholders increased 8% to EUR466M. Revenues reflect Diagnostics segment increase of 22% to EUR1.45B, Imaging segment increase of 9% to EUR2.45B, United States segment increase of 39% to EUR1.53B, Europe, C.I.S.,Africa,Middle East (without Germany) segment increase of 28% to EUR1.43B.

Latest shares articles

Buzzi Unicem logo displayed on a smartphone with a financial market chart in the background.
Buzzi stock forecast: H1 EBITDA and margin pressure
Buzzi is an Italian building-materials group listed in Milan, with recent trading shaped by a September share-price decline and a new investor presentation. Explore third-party BZU price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:07, 25 September 2026
PKO BP stock forecast: POLSTR mortgages, KNF penalties
PKO Bank Polski introduced POLSTR 1M-linked mortgages from 3 September and is seeking reconsideration of five KNF penalties totalling 47.5m PLN. Explore third-party PKO price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:40, 24 September 2026
Soitec logo displayed in front of a blurred stock market chart with green and red candlesticks.
Soitec stock forecast: €500m ORNANE bond
Soitec is a French semiconductor materials company. In September 2026, it placed €500m of 0.5% ORNANEs due in 2033, with settlement expected on 25 September. Explore third-party SOI price targets and technical analysis. Past performance is not a reliable indicator of future results.
10:51, 24 September 2026
Vossloh stock forecast: RTI acquisition expands digital rail
Vossloh is a German rail-infrastructure group that completed its acquisition of Rail Technology International on 15 September, expanding its digital inspection and analytics offering. Explore third-party VOS price targets. Past performance is not a reliable indicator of future results.
11:09, 23 September 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready